Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study

By Piccini P.  

Brain, Vol. 126, Iss. 5, 2003-05 ,pp. : 1127-1135

Oxford University Press

Access to resources Recommend Favorite

Language processing within the striatum: evidence from a PET correlation study in Huntington's disease

By Teichmann Marc   Gaura Véronique  

Brain, Vol. 131, Iss. 4, 2008-04 ,pp. : 1046-1056

Oxford University Press

Access to resources Recommend Favorite

Deficits in Striatal Dopamine D 2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease

By Araujo D.M.   Cherry S.R.   Tatsukawa K.J.   Toyokuni T.   Kornblum H.I.  

Experimental Neurology, Vol. 166, Iss. 2, 2000-12 ,pp. : 287-297

Elsevier

Access to resources Recommend Favorite

Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses

By Gabery Sanaz   Murphy Karen   Schultz Kristofer   Loy Clement   McCusker Elizabeth   Kirik Deniz   Halliday Glenda   Petersén Åsa  

Acta Neuropathologica, Vol. 120, Iss. 6, 2010-12 ,pp. : 777-788

Springer Publishing Company

Access to resources Recommend Favorite

¹⁸F-fluorodeoxyglucose-PET as a biomarker in Huntington’s disease

By Ciarmiello Andrea   Squitieri Ferdinando  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 489-491

Future Medicine

Access to resources Recommend Favorite